Literature DB >> 22634010

Acetaminophen inhibits cytochrome c redox cycling induced lipid peroxidation.

Huiyong Yin1, Aurélia Vergeade, Qiong Shi, William E Zackert, Katherine C Gruenberg, Magdalena Bokiej, Taneem Amin, Weizhen Ying, Tina S Masterson, Sandra S Zinkel, John A Oates, Olivier Boutaud, L Jackson Roberts.   

Abstract

Cytochrome (cyt) c can uncouple from the respiratory chain following mitochondrial stress and catalyze lipid peroxidation. Accumulating evidence shows that this phenomenon impairs mitochondrial respiratory function and also initiates the apoptotic cascade. Therefore, under certain conditions a pharmacological approach that can inhibit cyt c catalyzed lipid peroxidation may be beneficial. We recently showed that acetaminophen (ApAP) at normal pharmacologic concentrations can prevent hemoprotein-catalyzed lipid peroxidation in vitro and in vivo by reducing ferryl heme to its ferric state. We report here, for the first time, that ApAP inhibits cytochrome c-catalyzed oxidation of unsaturated free fatty acids and also the mitochondrial phospholipid, cardiolipin. Using isolated mitochondria, we also showed that ApAP inhibits cardiolipin oxidation induced by the pro-apoptotic protein, tBid. We found that the IC(50) of the inhibition of cardiolipin oxidation by ApAP is similar in both intact isolated mitochondria and cardiolipin liposomes, suggesting that ApAP penetrates well into the mitochondria. Together with our previous results, the findings presented herein suggest that ApAP is a pleiotropic inhibitor of peroxidase catalyzed lipid peroxidation. Our study also provides a potentially novel pharmacological approach for inhibiting the cascade of events that can result from redox cycling of cyt c.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634010      PMCID: PMC3389218          DOI: 10.1016/j.bbrc.2012.05.058

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  46 in total

1.  Formation of 4-hydroxynonenal from cardiolipin oxidation: Intramolecular peroxyl radical addition and decomposition.

Authors:  Wei Liu; Ned A Porter; Claus Schneider; Alan R Brash; Huiyong Yin
Journal:  Free Radic Biol Med       Date:  2010-11-01       Impact factor: 7.376

2.  Lipid oxidation in biological membranes. Electron transfer proteins as initiators of lipid autoxidation.

Authors:  R M Kaschnitz; Y Hatefi
Journal:  Arch Biochem Biophys       Date:  1975-11       Impact factor: 4.013

Review 3.  Free radical lipid peroxidation: mechanisms and analysis.

Authors:  Huiyong Yin; Libin Xu; Ned A Porter
Journal:  Chem Rev       Date:  2011-08-23       Impact factor: 60.622

4.  Pyridine and pyrimidine analogs of acetaminophen as inhibitors of lipid peroxidation and cyclooxygenase and lipoxygenase catalysis.

Authors:  Tae-Gyu Nam; Susheel J Nara; Irène Zagol-Ikapitte; Thomas Cooper; Luca Valgimigli; John A Oates; Ned A Porter; Olivier Boutaud; Derek A Pratt
Journal:  Org Biomol Chem       Date:  2009-10-20       Impact factor: 3.876

5.  Conformational properties of cardiolipin-bound cytochrome c.

Authors:  Jonas Hanske; Jason R Toffey; Anna M Morenz; Amber J Bonilla; Katherine H Schiavoni; Ekaterina V Pletneva
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-21       Impact factor: 11.205

Review 6.  Cholesterol and peroxidized cardiolipin in mitochondrial membrane properties, permeabilization and cell death.

Authors:  Joan Montero; Montserrat Mari; Anna Colell; Albert Morales; Gorka Basañez; Carmen Garcia-Ruiz; Jose C Fernández-Checa
Journal:  Biochim Biophys Acta       Date:  2010-02-11

7.  Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure.

Authors:  Olivier Boutaud; Kevin P Moore; Brandon J Reeder; David Harry; Alexander J Howie; Shuhe Wang; Clare K Carney; Tina S Masterson; Taneem Amin; David W Wright; Michael T Wilson; John A Oates; L Jackson Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

8.  Heterolytic reduction of fatty acid hydroperoxides by cytochrome c/cardiolipin complexes: antioxidant function in mitochondria.

Authors:  Natalia A Belikova; Yulia Y Tyurina; Grigory Borisenko; Vladimir Tyurin; Alejandro K Samhan Arias; Naveena Yanamala; Paul Georg Furtmüller; Judith Klein-Seetharaman; Christian Obinger; Valerian E Kagan
Journal:  J Am Chem Soc       Date:  2009-08-19       Impact factor: 15.419

9.  Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL.

Authors:  Rui Chen; Ariel E Feldstein; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

Review 10.  Reactive oxygen species, cellular redox systems, and apoptosis.

Authors:  Magdalena L Circu; Tak Yee Aw
Journal:  Free Radic Biol Med       Date:  2010-01-04       Impact factor: 7.376

View more
  6 in total

1.  Cardiolipin fatty acid remodeling regulates mitochondrial function by modifying the electron entry point in the respiratory chain.

Authors:  Aurelia Vergeade; Clinton C Bertram; Alfiya T Bikineyeva; William E Zackert; Sandra S Zinkel; James M May; Sergey I Dikalov; L Jackson Roberts; Olivier Boutaud
Journal:  Mitochondrion       Date:  2016-04-13       Impact factor: 4.160

2.  Rational Design of Novel Pyridinol-Fused Ring Acetaminophen Analogues.

Authors:  Roman V Shchepin; Wei Liu; Huiyong Yin; Irene Zagol-Ikapitte; Taneem Amin; Byeong-Seon Jeong; L Jackson Roberts; John A Oates; Ned A Porter; Olivier Boutaud
Journal:  ACS Med Chem Lett       Date:  2013-08-08       Impact factor: 4.345

3.  Tobacco smoking induces cardiovascular mitochondrial oxidative stress, promotes endothelial dysfunction, and enhances hypertension.

Authors:  Sergey Dikalov; Hana Itani; Bradley Richmond; Aurelia Vergeade; S M Jamshedur Rahman; Olivier Boutaud; Timothy Blackwell; Pierre P Massion; David G Harrison; Anna Dikalova
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-01-04       Impact factor: 4.733

4.  Mitochondrial Isolevuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension.

Authors:  Anna Dikalova; Vladimir Mayorov; Liang Xiao; Alexander Panov; Venkataraman Amarnath; Irene Zagol-Ikapitte; Aurelia Vergeade; Mingfang Ao; Valery Yermalitsky; Rafal R Nazarewicz; Olivier Boutaud; Marcos G Lopez; Frederic T Billings; Sean Davies; L Jackson Roberts; David G Harrison; Sergey Dikalov
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

5.  Formation of electrophilic oxidation products from mitochondrial cardiolipin in vitro and in vivo in the context of apoptosis and atherosclerosis.

Authors:  Huiqin Zhong; Jianhong Lu; Lin Xia; Mingjiang Zhu; Huiyong Yin
Journal:  Redox Biol       Date:  2014-04-13       Impact factor: 11.799

6.  Protective effect of paracetamol in doxorubicin-induced cardiotoxicity in ischemia/reperfused isolated rat heart.

Authors:  Mahvash Hesari; Dareuosh Shackebaei; Atefeh Asadmobini
Journal:  Anatol J Cardiol       Date:  2018-01-19       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.